Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029331 | 12602933 | 1 | I | 20160106 | 20160728 | 20160728 | EXP | US-BAYER-2016-004664 | BAYER | 80.00 | YR | E | F | Y | 90.70000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029331 | 12602933 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | Oral | 0.5 MG, TID | BXH5601 | 204819 | .5 | MG | TID | ||||||
| 126029331 | 12602933 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH7CK4 | 204819 | 2.5 | MG | TID | ||||||
| 126029331 | 12602933 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH8FC1 | 204819 | 2.5 | MG | TID | ||||||
| 126029331 | 12602933 | 4 | SS | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126029331 | 12602933 | 5 | C | APIXABAN | APIXABAN | 1 | UNK | 0 | |||||||||||
| 126029331 | 12602933 | 6 | C | LETAIRIS | AMBRISENTAN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126029331 | 12602933 | 1 | Pulmonary hypertension |
| 126029331 | 12602933 | 2 | Pulmonary hypertension |
| 126029331 | 12602933 | 3 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126029331 | 12602933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126029331 | 12602933 | Abdominal distension | |
| 126029331 | 12602933 | Blood glucose decreased | |
| 126029331 | 12602933 | Coma | |
| 126029331 | 12602933 | Contusion | |
| 126029331 | 12602933 | Cough | |
| 126029331 | 12602933 | Dyspnoea | |
| 126029331 | 12602933 | Fall | |
| 126029331 | 12602933 | Flatulence | |
| 126029331 | 12602933 | Fluid retention | |
| 126029331 | 12602933 | Hypotension | |
| 126029331 | 12602933 | Somnolence | |
| 126029331 | 12602933 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126029331 | 12602933 | 1 | 20151217 | 0 |